John Kenneth Amory
Director, Clarus Therapeutics (United States).
Companies
- Clarus Therapeutics (United States)Board member Sep 13, 2021 to Jun 9, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Clarus Therapeutics (United States)5,766 shares2Jun 7, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 7, 2022Granted 1,922 shares of Clarus Therapeutics (United States)2
- Dec 12, 2021Granted 3,844 shares of Clarus Therapeutics (United States)3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 14, 2021